WilliamRJarnaginMD

Surgical Oncology (Other than Breast)

Chief, Hepatopancreatobiliary Service at MSK Benno C. Schmidt Chair in Surgical Oncology

Overview of Dr. Jarnagin

Dr. William Jarnagin is a general surgeon in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan-Kettering Cancer Center and Memorial Sloan-Kettering Cancer Center. He received his medical degree from Rush Medical College and has been in practice 29 years. He specializes in surgical oncology (other than breast) and is experienced in cholangiocarcinoma, surgical oncology (non-breast), and hepatopancreatobiliary surgery.

Office
160 East 53rd Street
New York, NY 10022
Book by Phone+1(231) 508-8548

Education & Training

University of California (San Francisco)Residency, Surgery, 1988 - 1996
Rush Medical College of Rush University Medical CenterClass of 1988

Certifications & Licensure

CA State Medical License 1989 - Present
FL State Medical License 2021 - Present
NY State Medical License 1996 - 2025
American Board of Surgery Surgery

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2009-2014
Top Doctors: New York Metro Area Castle Connolly, 2009-2014
New York Magazine: Top Doctors Castle Connolly, 2009, 2011-2014
America's Top Doctors for Cancer Castle Connolly, 2008-2013
Fellow (FACS) American College of Surgeons
Join now to see all

Clinical Trials

Acute Normovolemic Hemodilution Versus Standard Intraoperative Management in Patients Having Hepatic Resection and Pancreaticoduodenectomy Start of enrollment: 2004 Mar 01
Completed
Phase 3
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery Start of enrollment: 2007 May 09
Completed
Phase 2
A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy Start of enrollment: 2003 Jun 01
Completed
Phase 2
Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer Start of enrollment: 2008 Apr 01
Completed
Controlled Trial Comparing Nomogram-based Versus Standard Allocation of Acute Normovolemic Hemodilution (ANH) During Hepatic Resection Start of enrollment: 2009 May 01
Completed
Phase 3
Feasibility of a Minimally Invasive Image-Guided Surgery System for Hepatic Procedures Start of enrollment: 2010 Aug 01
Completed
Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) Start of enrollment: 2013 May 01
Active, not recruiting
Phase 2
Join now to see all

Publications & Presentations

PubMed

Clinicogenomic landscape of pancreatic adenocarcinoma identifies KRAS mutant dosage as prognostic of overall survival.
Anna M Varghese, Maria A Perry, Joanne F Chou, Subhiksha Nandakumar, Daniel Muldoon
Nature Medicine. 2025-01-03
Impact of Financial Toxicity on Treatment Adherence and Quality of Life in Pancreatic Cancer.
Lauren E Schleimer, Emeline Aviki, Hannah L Kalvin, Josephine Magnin, Stefania S Sokolowski
JCO Oncology Practice. 2024-12-20
ASO Visual Abstract: Surgical Site Infections in Simultaneous Colorectal and Liver Resections for Metastatic Colorectal Adenocarcinoma.
Lauren E Schleimer, Lynn Hakki, Kenneth Seier, Susan K Seo, Nina Cohen
Annals of Surgical Oncology. 2024-12-18

Journal Articles

Questioning Why More Patients with Colorectal Liver Metastases Are Not Referred for Metastasectomy
Alice C Wei, William R Jarnagin, JAMA Surgery
Laparoscopic Liver Resection Difficulty Score—a Validation Study
Ryan P Merkow, William R Jarnagin, Journal of gastrointestinal surgery
Quantitative Imaging Features of Pretreatment CT Predict Volumetric Response to Chemotherapy in Patients with Colorectal Liver Metastases
Andrea Cercek, William R Jarnagin, Jinru Shia, Peter J Allen, Kenneth P Seastedt, Nancy E Kemeny, Ronald P DeMatteo, Vinod P Balachandran, T Peter Kingham, European Radiology

Authored Content

Questioning Why More Patients with Colorectal Liver Metastases Are Not Referred for MetastasectomyJuly 2020

Press Mentions

Pancreatic Cancer Surge May Be Less Worrisome Than It SeemedNovember 18th, 2024
Reprogrammed Cells Attack and Tame Deadly Cancer in One WomanJune 1st, 2022
Developing a Different Type of Liquid Biopsy to Detect CancerAugust 17th, 2020
Join now to see all

Grant Support

Clinical Translation Of Deformation Compensation For Image-Guided Liver SurgeryNational Cancer Institute2011
Hepatic Arterial Flouridine And IV Bevacizumab For Primary Hepatic MalignancyNational Cancer Institute2007–2008

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American College of Surgeons - ACS
Member

Insurance Accepted

BCBS Blue Card PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPO
Empire BCBS HMO
Empire BCBS PPO
GHI PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
MVP Healthcare PPO
QualCare HMO
QualCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO
Please verify your coverage with the provider's office directly when scheduling an appointment